{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:35:45Z","timestamp":1793230545040,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.tox.2021.152840","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T19:24:05Z","timestamp":1624562645000},"page":"152840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"special_numbering":"C","title":["Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms"],"prefix":"10.1016","volume":"458","author":[{"given":"Devaraj","family":"Ezhilarasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.152840_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174295","article-title":"Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity","volume":"12","author":"Abo-Haded","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2021.152840_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0015","series-title":"Drug-Induced Liver Disease","article-title":"Hepatotoxicity related to methotrexate","author":"Aithal","year":"2013"},{"key":"10.1016\/j.tox.2021.152840_bib0020","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/molecules25112540","article-title":"Ginkgo biloba extract protects against methotrexate-induced hepatotoxicity: a computational and pharmacological approach","volume":"25","author":"Al Kury","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.tox.2021.152840_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.etap.2010.10.001","article-title":"Protective role of taurine against genotoxic damage in mice treated with methotrexate and tamoxfine","volume":"31","author":"Alam","year":"2011","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2017.05.002","article-title":"Protective effect of Chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach","volume":"272","author":"Ali","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2021.152840_bib0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","article-title":"Drug-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0040","first-page":"1313","article-title":"The combined effect of honey and olive oil against methotrexate mediated hepatotoxicity in rats: a biochemical, histological and immunohistological study","volume":"34","author":"Alturkistani","year":"2019","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.tox.2021.152840_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tox.2021.152840_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.tox.2021.152840_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/JCD.S39824","article-title":"Mechanism of hepatocyte apoptosis","volume":"9","author":"Cao","year":"2016","journal-title":"J. Cell Death"},{"key":"10.1016\/j.tox.2021.152840_bib0065","first-page":"BR274","article-title":"N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats","volume":"12","author":"Cetinkaya","year":"2006","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.tox.2021.152840_bib0070","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","article-title":"Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis","volume":"148","author":"Chan","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113209","article-title":"Protective effects of Glycyrrhiza glabra supplementation against methotrexate-induced hepato-renal damage in rats: an experimental approach","volume":"263","author":"Chauhan","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PTT.S141629","article-title":"Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography","volume":"8","author":"Cheng","year":"2018","journal-title":"Psoriasis"},{"key":"10.1016\/j.tox.2021.152840_bib0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.tox.2021.152840_bib0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0973-1482.140809","article-title":"Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction","volume":"11","author":"Cure","year":"2015","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.tox.2021.152840_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/pgs.12.183","article-title":"Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate","volume":"14","author":"D\u00e1vila-Fajardo","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.tox.2021.152840_bib0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00210-020-01810-8","article-title":"\u03b2-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats","volume":"393","author":"Devaraj","year":"2020","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0105","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.cgh.2017.05.031","article-title":"Features and treatment of dapsone-induced hepatitis, based on analysis of 44 cases and literature review","volume":"15","author":"Devarbhavi","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0110","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13662","article-title":"Drug-induced acute liver failure in children and adults: results of a single-centre study of 128 patients","volume":"38","author":"Devarbhavi","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.tox.2021.152840_bib0115","doi-asserted-by":"crossref","first-page":"929","DOI":"10.14309\/ajg.0000000000000201","article-title":"Drug-induced acute-on-chronic liver failure in Asian patients","volume":"114","author":"Devarbhavi","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tox.2021.152840_bib0120","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines","author":"Devarbhavi","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.tox.2021.152840_bib0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40199-019-00309-9","article-title":"Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the I\u0138B\u03b1\/NF\u0138B in rats","volume":"27","author":"Ebrahimi","year":"2019","journal-title":"Daru"},{"key":"10.1016\/j.tox.2021.152840_bib0130","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193686","article-title":"Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells","volume":"40","author":"Elsawy","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajg.2018.03.002","article-title":"Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective","volume":"19","author":"Ezhilarasan","year":"2018","journal-title":"Arab J. Gastroenterol."},{"key":"10.1016\/j.tox.2021.152840_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0145","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/1535370220949148","article-title":"Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells","volume":"245","author":"Ezhilarasan","year":"2020","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tox.2021.152840_bib0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/01480545.2019.1679829","article-title":"Dapsone-induced hepatic complications: it\u2019s time to think beyond methemoglobinemia","volume":"44","author":"Ezhilarasan","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2021.152840_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22697","article-title":"Boldine treatment protects acetaminophen-induced liver inflammation and acute hepatic necrosis in mice","volume":"35","author":"Ezhilarasan","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tox.2021.152840_bib0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jceh.2016.01.002","article-title":"Silibinin inhibits proliferation and migration of human hepatic stellate LX-2 cells","volume":"6","author":"Ezhilarasan","year":"2016","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0165","first-page":"220","article-title":"HAART and hepatotoxicity","volume":"7","author":"Ezhilarasan","year":"2017","journal-title":"J. App. Pharm. Sci."},{"key":"10.1016\/j.tox.2021.152840_bib0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.tox.2021.152840_bib0175","article-title":"Drug-induced liver injury caused by amoxicillin\/clavulanate","volume":"12","author":"Ferreira","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.tox.2021.152840_bib0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.tox.2021.152840_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.reuma.2015.12.005","volume":"12","author":"Gal\u00edndez","year":"2016","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.tox.2021.152840_bib0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.tox.2021.152840_bib0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00210-020-01991-2","article-title":"Protective effects of apigenin on altered lipid peroxidation, inflammation, and antioxidant factors in methotrexate-induced hepatotoxicity","volume":"394","author":"Goudarzi","year":"2021","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0200","first-page":"293","article-title":"Cancer chemotherapy: targeting folic acid synthesis","volume":"2","author":"Hagner","year":"2010","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tox.2021.152840_bib0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14397595.2017.1414765","article-title":"Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: a hospital based-cohort study","volume":"28","author":"Hakamata","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.tox.2021.152840_bib0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13075-015-0814-z","article-title":"Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study","volume":"17","author":"Hawwa","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tox.2021.152840_bib0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-800223-0.00004-9","article-title":"Biology of the major facilitative folate transporters SLC19A1 and SLC46A1","volume":"73","author":"Hou","year":"2014","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.tox.2021.152840_bib0220","doi-asserted-by":"crossref","first-page":"20725","DOI":"10.1007\/s11356-020-08557-y","article-title":"Chicoric acid prevents methotrexate hepatotoxicity via attenuation of oxidative stress and inflammation and up-regulation of PPAR\u03b3 and Nrf2\/HO-1 signaling","volume":"27","author":"Hussein","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.tox.2021.152840_bib0225","doi-asserted-by":"crossref","first-page":"20359","DOI":"10.1038\/s41598-019-56900-2","article-title":"Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein","volume":"9","author":"Ikemura","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0230","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/1756-185X.13576","article-title":"Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of predictors, surveillance, and outcome in clinical practice","volume":"22","author":"Karlsson Sundbaum","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0235","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/15376516.2016.1191576","article-title":"Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis","volume":"26","author":"Kelleni","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tox.2021.152840_bib0240","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237512","article-title":"High-dose methotrexate-induced reversible grade 4 hyperbilirubinaemia and transaminitis in an adolescent with Burkitt Leukaemia","volume":"14","author":"Khera","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0245","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-021-02995-4","article-title":"Nrf2: a main responsive element in cells to mycotoxin-induced toxicity","author":"Kozie\u0142","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2021.152840_bib0250","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/ijms21103483","article-title":"Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers","volume":"21","author":"Ko\u017ami\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2021.152840_bib0255","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/0253-7613.144940","article-title":"Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy","volume":"46","author":"Ksouda","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.tox.2021.152840_bib0260","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.tox.2021.152840_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cld.765","article-title":"Noninvasive tests to monitor methotrexate-induced liver injury","volume":"13","author":"Labadie","year":"2019","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"10.1016\/j.tox.2021.152840_bib0270","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","article-title":"Drug-induced liver injury","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tox.2021.152840_bib0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/1756-185X.13442","article-title":"Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate","volume":"22","author":"Lertnawapan","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0285","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1007\/s11356-019-07532-6","article-title":"Ferulic acid prevents oxidative stress, inflammation, and liver injury via upregulation of Nrf2\/HO-1 signaling in methotrexate-induced rats","volume":"27","author":"Mahmoud","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.tox.2021.152840_bib0290","first-page":"369","article-title":"Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up","volume":"10","author":"Malatjalian","year":"1996","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.tox.2021.152840_bib0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjd.12782","article-title":"Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study","volume":"171","author":"Martyn-Simmons","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2021.152840_bib0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2169\/internalmedicine.54.3361","article-title":"Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis","volume":"54","author":"Miyagawa","year":"2015","journal-title":"Intern. Med."},{"key":"10.1016\/j.tox.2021.152840_bib0305","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/14397595.2018.1542962","article-title":"Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate","volume":"29","author":"Miyata","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.tox.2021.152840_bib0310","first-page":"372","article-title":"Ethanolic extract of Iris songarica rhizome attenuates methotrexate-induced liver and kidney damages in rats","volume":"10","author":"Moodi","year":"2020","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.tox.2021.152840_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203084","article-title":"Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment","volume":"13","author":"Mori","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2021.152840_bib0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2021.152840_bib0325","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13256-019-2135-3","article-title":"Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature","volume":"13","author":"Ono","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0330","first-page":"1961","article-title":"Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis","volume":"8","author":"Osuga","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.tox.2021.152840_bib0335","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3899\/jrheum.181312","article-title":"Liver abnormalities in patients with psoriatic arthritis","volume":"47","author":"Pakchotanon","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.tox.2021.152840_bib0340","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000001341","article-title":"Albendazole-induced liver injury","author":"Piloiu","year":"2021","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.tox.2021.152840_bib0345","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1503\/cmaj.181054","article-title":"Low-dose methotrexate toxicity","volume":"191","author":"Pivovarov","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.tox.2021.152840_bib0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13256-020-2349-4","article-title":"Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report","volume":"14","author":"Pliquett","year":"2020","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0355","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/ajd.12521","article-title":"The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting","volume":"58","author":"Rademaker","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.tox.2021.152840_bib0360","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","article-title":"Antioxidant response elements: discovery, classes, regulation and potential applications","volume":"17","author":"Raghunath","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.tox.2021.152840_bib0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0039-1679919","article-title":"Acetaminophen hepatotoxicity","volume":"39","author":"Ramachandran","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0370","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/annonc\/mdx158","article-title":"Drug-induced liver injury in oncology","volume":"28","author":"Ricart","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tox.2021.152840_bib0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00403-017-1733-4","article-title":"Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study","volume":"309","author":"Rongngern","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.tox.2021.152840_bib0380","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0385","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.tox.2021.152840_bib0390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cld.2016.08.007","article-title":"Drug-induced liver disease: clinical course","volume":"21","author":"Saithanyamurthi","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0395","article-title":"Hepatoprotective effect of Ginkgo biloba extract against methotrexate-induced hepatotoxicity via targeting STAT3\/miRNA-21 axis","author":"Sherif","year":"2020","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2021.152840_bib0400","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","article-title":"Methotrexate hepatotoxicity and the impact of nonalcoholic fatty liver disease","volume":"354","author":"Shetty","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.tox.2021.152840_bib0405","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/art.30457","article-title":"Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK","volume":"63","author":"Spurlock","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tox.2021.152840_bib0410","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep4.1088","article-title":"Drug-induced cholestasis","volume":"1","author":"Sundaram","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tox.2021.152840_bib0415","doi-asserted-by":"crossref","first-page":"22387","DOI":"10.1038\/srep22387","article-title":"Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B","volume":"6","author":"Tang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0420","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2018.05.004","article-title":"Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: real-world data from a nationwide cohort study in Taiwan","volume":"79","author":"Tang","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tox.2021.152840_bib0425","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2021.152840_bib0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00044011-200626020-00001","article-title":"Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis","volume":"26","author":"Tilling","year":"2006","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.tox.2021.152840_bib0435","first-page":"95","article-title":"Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis","volume":"12","author":"Topalo\u011flu","year":"2014","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.tox.2021.152840_bib0440","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/bjd.15313","article-title":"Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications","volume":"177","author":"van den Reek","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tox.2021.152840_bib0445","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis","volume":"41","author":"van Ede","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.tox.2021.152840_bib0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2013.06.234","article-title":"Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients","volume":"221","author":"van Swelm","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2021.152840_bib0455","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tox.2021.152840_bib0460","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9343(05)80060-9","article-title":"Methotrexate and histologic hepatic abnormalities: a meta-analysis","volume":"90","author":"Whiting-O\u2019Keefe","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tox.2021.152840_bib0465","doi-asserted-by":"crossref","first-page":"35615","DOI":"10.1038\/srep35615","article-title":"Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis","volume":"6","author":"Yamamoto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2021.152840_bib0470","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4254\/wjh.v5.i5.275","article-title":"Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis","volume":"5","author":"Yeo","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0475","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.tox.2021.152840_bib0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical role of microRNA-21 in the pathogenesis of liver diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tox.2021.152840_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:47:28Z","timestamp":1759535248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21001633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":97,"alternative-id":["S0300483X21001633"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.152840","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.152840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152840"}}